Cellebrite DI Achieves Strong Q1 Revenue Growth
Company Announcements

Cellebrite DI Achieves Strong Q1 Revenue Growth

Cellebrite DI (CLBT) has released an update.

Cellebrite DI reports a robust start to 2024 with a 27% year-over-year increase in Annual Recurring Revenue (ARR) hitting $331.8 million, and a 26% surge in Q1 revenue amounting to $89.6 million, primarily driven by a significant 29% growth in subscription revenue. The company also notes a solid adjusted EBITDA of $17.6 million, attributing its strong performance to global business expansion and the successful market adoption of its new Inseyets digital forensics software.

For further insights into CLBT stock, check out TipRanks’ Stock Analysis page.

Related Articles
GlobeNewswireCellebrite Advances Plans to Transform and Elevate its Strategic Relationship with the U.S. Federal Government
GlobeNewswireCellebrite to Report Second-Quarter 2024 Financial Results on August 15, 2024
GlobeNewswireCellebrite Announces Availability of Industry-Leading Endpoint Inspector SaaS Solution on Amazon Web Services Marketplace
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!